\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\ \(73\)\
\-\ no\\ treatment\\.\ \(2\)\
\-\ multiple\\ extra\\ spinal\\ neurofibromas\\ involving\\ lumbosacral\\ plexus\\.\\ \\ neurofibromas\\ are\\ isointense\\ with\\ muscle\\ on\\ t1\\ scans\\,\\ hyperintense\\ on\\ t2\\ scans\\,\\ and\\ do\\ not\\ enhance\\ to\\ any\\ significant\\ degree\\ after\\ gadolinium\\ contrast\\.\ \(0\)\
\-\ neurofibromatosis\\ type\\ 1\\ with\\ lumbosacral\\ plexus\\ involvement\\.\ \(0\)\
\-\ none\ \(204\)\
\-\ 14\\ y\\.o\\.\\ girl\\ with\\ known\\ diagnosis\\ \\.\\.\\.\\ routine\\ follow\\-up\\ imaging\\ of\\ spine\\.\\ \\ currently\\ no\\ symptoms\\.\ \(0\)\
\-\ this\\ teen\\ age\\ girl\\ had\\ a\\ known\\ prior\\ diagnosis\\ of\\ neurofibromatosis\\ type\\ i\\ and\\ this\\ was\\ a\\ routine\\ surveillance\\ exam\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ neurofibromas\\:\\ 0\\.1455313051535287\ \(0\)\
\-\ lumbosacral\\:\\ 0\\.11673215645248573\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.1085327324538942\ \(0\)\
\-\ teen\\:\\ 0\\.10132779797662642\ \(0\)\
\-\ plexus\\:\\ 0\\.09545009953688348\ \(0\)\
\-\ scans\\:\\ 0\\.09147670154057518\ \(0\)\
\-\ routine\\:\\ 0\\.0787688895206896\ \(0\)\
\-\ girl\\:\\ 0\\.06906614783884593\ \(0\)\
\-\ type\\:\\ 0\\.0662212466286646\ \(0\)\
\-\ \\.\\.\\.\\:\\ 0\\.062233575198900486\ \(0\)\
\-\ known\\:\\ 0\\.06216209389571999\ \(0\)\
\-\ extra\\:\\ 0\\.06149175311685944\ \(0\)\
\-\ surveillance\\:\\ 0\\.0611380558908048\ \(0\)\
\-\ isointense\\:\\ 0\\.0482804357140832\ \(0\)\
\-\ enhance\\:\\ 0\\.04751019766485377\ \(0\)\
\-\ gadolinium\\:\\ 0\\.04659016654216945\ \(0\)\
\-\ degree\\:\\ 0\\.046015334121771036\ \(0\)\
\-\ diagnosis\\:\\ 0\\.045108490362768275\ \(0\)\
\-\ 14\\:\\ 0\\.043283476054217944\ \(0\)\
\-\ do\\:\\ 0\\.04263876954098756\ \(0\)\
\-\ hyperintense\\:\\ 0\\.04077770419428931\ \(0\)\
\-\ i\\:\\ 0\\.04060131833595988\ \(0\)\
\-\ currently\\:\\ 0\\.038921526379448936\ \(0\)\
\-\ involvement\\:\\ 0\\.035999294903768006\ \(0\)\
\-\ muscle\\:\\ 0\\.03527948544168213\ \(0\)\
\-\ spinal\\:\\ 0\\.035169841498615934\ \(0\)\
\-\ involving\\:\\ 0\\.034464451310382685\ \(0\)\
\-\ available\\:\\ 0\\.033019759182066635\ \(0\)\
\-\ spine\\:\\ 0\\.03234601777017641\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.03195444817749129\ \(0\)\
\-\ t1\\:\\ 0\\.031132132600278663\ \(0\)\
\-\ any\\:\\ 0\\.03092913831117579\ \(0\)\
\-\ age\\:\\ 0\\.02989552098326789\ \(0\)\
\-\ not\\:\\ 0\\.028386636131998513\ \(0\)\
\-\ y\\.o\\:\\ 0\\.028349188880306898\ \(0\)\
\-\ t2\\:\\ 0\\.02779987090517646\ \(0\)\
\-\ significant\\:\\ 0\\.02641203621901406\ \(0\)\
\-\ prior\\:\\ 0\\.025219687036808776\ \(0\)\
\-\ symptoms\\:\\ 0\\.02447882157354183\ \(0\)\
\-\ none\\:\\ 0\\.024364592033425364\ \(0\)\
\-\ 1\\:\\ 0\\.023371567447812724\ \(0\)\
\-\ imaging\\:\\ 0\\.023012342809834514\ \(0\)\
\-\ this\\:\\ 0\\.022095108352049034\ \(0\)\
\-\ contrast\\:\\ 0\\.021985927434573622\ \(0\)\
\-\ exam\\:\\ 0\\.02157740160861538\ \(0\)\
\-\ had\\:\\ 0\\.02119367608322653\ \(0\)\
\-\ multiple\\:\\ 0\\.02068742532734792\ \(0\)\
\-\ after\\:\\ 0\\.020321852903554052\ \(0\)\
\-\ treatment\\:\\ 0\\.019880654708056174\ \(0\)\
\-\ no\\:\\ 0\\.019780325303535677\ \(0\)\
\-\ on\\:\\ 0\\.016641172698055817\ \(0\)\
\-\ are\\:\\ 0\\.01338935485666209\ \(0\)\
\-\ was\\:\\ 0\\.011359511749582607\ \(0\)\
\-\ a\\:\\ 0\\.00911723682341612\ \(0\)\
\-\ \\,\\:\\ 0\\.006223219896949135\ \(0\)\
\-\ to\\:\\ 0\\.004908828832678003\ \(0\)\
\-\ and\\:\\ 0\\.00413813806280962\ \(0\)\
\-\ with\\:\\ 0\\.004034626761720336\ \(0\)\
\-\ \\.\\:\\ 0\\.0032643251583766688\ \(0\)\
\-\ of\\:\\ 0\\.0026782482942066307\ \(0\)\
